This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
fact-checked
trusted source
proofread
BF23 bacteriophage study reveals that viruses can cope with bacterial restriction and modification
Bacteriophages are natural "predators" and enemies of bacteria. They are able to recognize specific types of bacteria and are considered safe for humans. Due to the increasing resistance of pathogenic microorganisms to antibiotics, bacteriophages have recently been considered as a possible alternative to antibiotics.
In a recent study, a group of scientists from Skoltech Laboratory of Metagenome Analysis led by Artem Isaev, drew attention to the BF23 bacteriophage. Although it was found in 1949, the genomic sequence of the phage remained unknown. The researchers conducted genomic and proteomic analysis of the phage, and investigated how the phage interacts with bacterial immunity systems.
The study is published in the microLife journal.
"T5-like bacteriophages are very protected viruses. For some reason, they masterfully deceive different bacterial immune systems: restriction modification and CRISPR-Cas, which are based on cutting any foreign DNA. For many years, scientists have been trying to figure out how they do this—they are looking for proteins that could represent novel inhibitors of RM systems, but so far they haven't succeeded," says the leading author of the study Mikhail Skutel, a Ph.D. student at Skoltech.
"Therefore, the BF23 phage was interesting to us for two reasons: we wanted to compare its genomic sequence with other T5-like viruses and try to use it as a model to explain how T5 bypasses protective systems."
The scientists sequenced the genome and compared it with the genomes of other T5-like phages. Although the changes in the BF23's genome are insignificant, the comparative analysis should guide the search for an "anti-restriction component," since such protein should be conserved among all T5-like phages.
Unlike other bacteriophages, which immediately inject all their genomic material into a bacterial cell, T5-like phages carry out infection in two stages and first inject only a small part of their genome, which is required to prepare the cell for successful infection.
"At the first stage of infection, special early phage genes begin to work actively and many interesting things happen: not only the genome of the bacterial cell is completely destroyed, but also the nucleotides themselves—the building blocks that make up the genomic DNA of bacteria. Apparently, it is at this stage that the phage is producing a component that will subsequently protect the rest of the phage genome from bacterial immune enzymes," adds Mikhail Skutel.
In the article, the authors tested the action of several T5-like bacteriophages against a variety of restriction modification protection systems. These systems recognize and cut special DNA sequences if they do not have a protective label—methyl group.
It turned out that the cell is protected from infection only when the recognition sites are located in the very early part of the genome that penetrates the cell at the first stage of infection. For yet undetermined reasons, sites located in the rest of the genome remain invisible to bacterial nucleases. Presumably, at the second stage of infection, the nucleases have already been inactivated by the phage, or the phage was able to protect its own DNA.
More information: Mikhail Skutel et al, T5-like phage BF23 evades host-mediated DNA restriction and methylation, microLife (2023). DOI: 10.1093/femsml/uqad044
Provided by Skolkovo Institute of Science and Technology